患有类风湿关节炎的Medicare受益人中原发性年龄相关性黄斑变性诊断增加
该研究利用MarketScan数据库中≥65岁Medicare受益人数据,按倾向评分匹配类风湿关节炎(RA)患者与无RA对照,随访至4.5年,发现RA患者新发AMD诊断风险升高(OR 2.08;95%CI 1.98-2.18),且非渗出性AMD患者增加(P<0.0001),RA患者首次AMD诊断时间较对照缩短(P<0.0001)。
要点
- RA患者新发AMD诊断风险升高(OR 2.08;95%CI 1.98-2.18)。
- RA患者非渗出性AMD诊断增加(P<0.0001)。
- RA患者首次AMD诊断时间较对照缩短(P<0.0001)。
核心结论
- 分析支持RA诊断与非渗出性AMD诊断增加之间存在关联。
研究设计与样本
- 从MarketScan数据库中提取≥65岁Medicare受益人基线数据,RA组需至少两条ICD-9诊断代码,对照组无RA,按倾向评分在基线匹配,匹配后队列随访至4.5年,检查ICD-9诊断代码AMD记录。
主要发现
- RA患者新发AMD诊断风险升高(OR 2.08;95%CI 1.98-2.18),非渗出性AMD患者增加(P<0.0001)。
- 女性RA患者(n=27,548)AMD风险升高(OR 1.11;95%CI 1.05-1.17),与男性(n=9704)相比差异有统计学意义(P<0.001)。
- RA患者首次AMD诊断时间较对照缩短(P<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: AMD is the leading cause of blindness in the United States. The role of secondary inflammatory disease on AMD progression is largely unknown. Here we investigate the association between AMD and rheumatoid arthritis (RA), using MarketScan data for patients aged ≥65 years on Medicare. METHODS: Baseline data were extracted for subjects with at least two International Classification, Ninth Revision (ICD-9) diagnosis codes of RA and control subjects (no RA) and were matched at baseline by propensity score. Matched cohort data were extracted post-baseline time and examined up to 4.5 years of follow-up for ICD-9 diagnosis code AMD records. Multivariable regression models compared risk of an AMD diagnosis post-baseline for RA subjects and matched controls. Days until first AMD diagnosis between RA patients and controls was examined using survival analysis. RESULTS: Risk of new AMD diagnosis was elevated in RA patients (odds ratio [OR] 2.08; 95% confidence interval [CI] 1.98-2.18), with an increase in nonexudative AMD patients (P < 0.0001). Risk was elevated in female (n = 27,548) (OR 1.11; 95% CI 1.05-1.17) compared with male (n = 9704; P < 0.001) patients. The time to first AMD diagnosis was shorter for RA subjects than controls (P < 0.0001). CONCLUSIONS: Our analysis provides support of association between RA diagnosis and increased nonexudative AMD diagnosis.
引用
- Schnabolk G, Rohrer B, Simpson KN, et al. Increased Nonexudative Age-Related Macular Degeneration Diagnosis Among Medicare Beneficiaries With Rheumatoid Arthritis. Invest Ophthalmol Vis Sci. 2019. PMID: 31412111. doi:10.1167/iovs.18-26444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。